Beijing Double-Crane Pharmaceutical Company Limited (600062) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Beijing Double-Crane Pharmaceutical Company Limited Company Snapshot

Business Description:

Beijing Double-Crane Pharmaceutical Company Limited operates in the Medicinals and botanicals sector. Beijing Double-Crane Pharmaceutical Co., Ltd. is principally engaged in manufacture, processing and distribution of pharmaceuticals. The Company's products are classified into three categories: infusion solutions, cardiovascular drugs and endocrine secretion drugs, including vitamin E and C granules, ofloxacin (antimicrobial drug), levofloxacin mesylate (antimicrobial drugs) and metformin hydrochloride tablets, among others. The Company distributes its products primarily in domestic market. In our complete report available for purchase the company is compared to: Chongqing Taiji Industry (Group), Shanghai Fosun Pharmaceutical (Group) Company Limited and Zhejiang Hisun Pharmaceutical, Ltd..

Beijing Double-Crane Pharmaceutical Company Limited

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): 14.25
(Figures in Chinese Renmimbi)

1 Week	2.2%	13 Weeks	8.6%

4 Weeks	-21.4%	52 Weeks	-47.0%

Beijing Double-Crane Pharmaceutical Company Limited Key Data:

Ticker:	600062	Country:	CHINA

Exchanges:	SHG	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	5,363,800,000 (Year Ending Jan 2011).	Employees:	11,211

Currency:	Chinese Renmimbi	Market Cap:	8,146,667,259

Fiscal Yr Ends:	December	Shares Outstanding:	571,695,948

Share Type:	A Gu	Closely Held Shares:	280,913,116

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.